Tapingo
Tapingo
Tapingo was a mobile commerce application that allowed users to order food and beverages for pickup or delivery. It was primarily targeted at college campuses, providing a convenient way for students to order from campus dining facilities and nearby restaurants.
History
Tapingo was founded in 2012 by Daniel Almog and Udi Oster. The company was headquartered in San Francisco, California. Tapingo quickly gained popularity among college students due to its user-friendly interface and the ability to integrate with campus meal plans.
In 2018, Tapingo was acquired by Grubhub, a leading online and mobile food-ordering company, for $150 million. This acquisition allowed Grubhub to expand its presence on college campuses across the United States.
Features
Tapingo offered several features that made it appealing to its users:
- Order Ahead: Users could place orders in advance and pick them up at a designated time, reducing wait times.
- Delivery: Tapingo provided delivery services, allowing students to receive food directly at their dorms or other campus locations.
- Integration with Meal Plans: The app could integrate with university meal plans, enabling students to use their meal credits for purchases.
- Customizable Menus: Restaurants could offer customizable menu options, allowing users to tailor their orders to their preferences.
Impact on College Campuses
Tapingo revolutionized the way students interacted with campus dining services. By providing a seamless ordering experience, it reduced congestion in dining halls and increased efficiency for both students and dining staff. The app's integration with meal plans also encouraged more students to utilize their campus dining facilities.
Acquisition by Grubhub
The acquisition by Grubhub allowed Tapingo to leverage Grubhub's extensive network and resources. This partnership expanded Tapingo's reach and improved its service offerings. Grubhub's acquisition strategy focused on enhancing its presence in the college market, where Tapingo had already established a strong foothold.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD